BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Vaxart, Inc. 

600 Townsend Street
Suite 120E
San Francisco  California  94103  U.S.A.
Phone: 415-437-0132 Fax:


SEARCH JOBS




Industry
Biotechnology

Segment
Vaccines





 Company News
Vaxart, Inc.’s Tablet Vaccine For H1N1 Influenza Generates Protective Immunity Equivalent To Injectable In Phase I Clinical Study 10/14/2014 8:09:47 AM
Vaxart, Inc. To Present At The JMP Securities Life Sciences Private Company Conference On Friday, October 17, 2014 10/9/2014 10:42:39 AM
Vaxart, Inc. To Present At The 15th Annual World Vaccine Congress In Brussels 10/8/2014 7:57:50 AM
Vaxart, Inc. Appoints John Harland As Chief Financial Officer 5/8/2014 9:36:00 AM
Vaxart, Inc.’s Oral H1N1 Influenza Vaccine Generates Protective Immunity 1/9/2014 10:20:57 AM
Flu Vaccine Developer Vaxart, Inc. Snags $20 Million 8/7/2013 7:55:33 AM
Vaxart, Inc. Creates Effective Oral H7N9 Avian Influenza Vaccine in 20 Days 6/26/2013 9:43:04 AM
Vaxart, Inc.’s Groundbreaking Tablet Influenza Vaccine Generates Protective Antibody Levels in Humans 6/19/2013 9:47:53 AM
Vaxart, Inc. Begins First Oral Vaccine Clinical Trial 6/7/2011 11:14:11 AM
Vaxart, Inc. Raises $12.5 Million Series B 3/4/2010 7:43:56 AM
12